Charles River Labs Intl Stock
Price
Target price
€198.30
€198.30
0.530%
1.05
0.530%
€189.46
13:01 / Tradegate
WKN: 939391 / Symbol: CRL / Name: Charles River Lb / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Charles River Labs Intl Stock
The Charles River Labs Intl stock is trending slightly upwards today, with an increase of €1.05 (0.530%) compared to yesterday's price.
With 22 Buy predictions and not a single Sell prediction Charles River Labs Intl is an absolute favorite of our community.
However, we have a potential of -4.69% for Charles River Labs Intl as the target price of 189 € is below the current price of 198.3 €.
Pros and Cons of Charles River Labs Intl in the next few years
Pros
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
B****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Charles River Labs Intl vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Charles River Labs Intl | 0.530% | 2.754% | 6.389% | 33.798% | 16.710% | 4.975% | -39.671% |
| Ligand Pharmaceuticals | 0.000% | 1.550% | -1.504% | 125.862% | 57.831% | 326.016% | 156.989% |
| United Therapeutics | -0.910% | 0.065% | -2.561% | 78.913% | 8.612% | 109.621% | 197.500% |
| Ionis Pharmaceuticals Inc. | -1.470% | 6.144% | -30.959% | 36.892% | -27.546% | 40.245% | 60.078% |
Comments
Charles River Laboratories International (CRL) had its "overweight" rating reaffirmed by Morgan Stanley.
Show more
Ratings data for CRL provided by MarketBeat
Charles River Laboratories International (CRL) had its "buy" rating reaffirmed by Citigroup Inc..
Show more
Ratings data for CRL provided by MarketBeat
Charles River Laboratories International (CRL) was upgraded by Morgan Stanley from "equal weight" to "overweight". They now have a $220.00 price target on the stock, up from $185.00.
Show more
Ratings data for CRL provided by MarketBeat